Jazz Ebt Per Ebit from 2010 to 2024

JAZZ Stock  USD 105.25  0.21  0.20%   
Jazz Pharmaceuticals Ebt Per Ebit yearly trend continues to be fairly stable with very little volatility. Ebt Per Ebit is likely to outpace its year average in 2024. During the period from 2010 to 2024, Jazz Pharmaceuticals Ebt Per Ebit regression line of annual values had r-squared of  0.42 and arithmetic mean of  0.61. View All Fundamentals
 
Ebt Per Ebit  
First Reported
2010-12-31
Previous Quarter
0.45190056
Current Value
0.66
Quarterly Volatility
0.57330153
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Jazz Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jazz main balance sheet or income statement drivers, such as Interest Expense of 368.7 M, Other Operating Expenses of 3.3 B or Operating Income of 692.2 M, as well as many exotic indicators such as Price To Sales Ratio of 1.93, Dividend Yield of 0.0 or PTB Ratio of 2.98. Jazz financial statements analysis is a perfect complement when working with Jazz Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Jazz Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Jazz Pharmaceuticals Technical models . Check out the analysis of Jazz Pharmaceuticals Correlation against competitors.

Latest Jazz Pharmaceuticals' Ebt Per Ebit Growth Pattern

Below is the plot of the Ebt Per Ebit of Jazz Pharmaceuticals PLC over the last few years. It is Jazz Pharmaceuticals' Ebt Per Ebit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jazz Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Ebt Per Ebit10 Years Trend
Slightly volatile
   Ebt Per Ebit   
       Timeline  

Jazz Ebt Per Ebit Regression Statistics

Arithmetic Mean0.61
Geometric Mean0.77
Coefficient Of Variation93.23
Mean Deviation0.41
Median0.85
Standard Deviation0.57
Sample Variance0.33
Range2.0107
R-Value(0.65)
Mean Square Error0.21
R-Squared0.42
Significance0.01
Slope(0.08)
Total Sum of Squares4.60

Jazz Ebt Per Ebit History

2024 0.66
2023 0.45
2022 -0.73
2021 -0.66
2020 0.36
2019 0.85

About Jazz Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Jazz Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Jazz Pharmaceuticals investors use historical funamental indicators, such as Jazz Pharmaceuticals's Ebt Per Ebit, to determine how well the company is positioned to perform in the future. Although Jazz Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Jazz Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Jazz Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Jazz Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Jazz Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Ebt Per Ebit 0.45  0.66 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Jazz Pharmaceuticals PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Jazz Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Jazz Pharmaceuticals Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Jazz Pharmaceuticals Plc Stock:
Check out the analysis of Jazz Pharmaceuticals Correlation against competitors.
Note that the Jazz Pharmaceuticals PLC information on this page should be used as a complementary analysis to other Jazz Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Jazz Stock analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Is Jazz Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Jazz Pharmaceuticals. If investors know Jazz will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Jazz Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.757
Earnings Share
4.83
Revenue Per Share
60.956
Quarterly Revenue Growth
0.01
Return On Assets
0.0407
The market value of Jazz Pharmaceuticals PLC is measured differently than its book value, which is the value of Jazz that is recorded on the company's balance sheet. Investors also form their own opinion of Jazz Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Jazz Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Jazz Pharmaceuticals' market value can be influenced by many factors that don't directly affect Jazz Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Jazz Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Jazz Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Jazz Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.